Gene mutations that affect drug metabolism may explain higher hospitalization rates for some older adults taking multiple medications, according to researchers from Columbia University.
More than one in four older adults have not engaged in planning for end-of-life care or directives, despite significant public efforts to encourage the practice. This is especially true for African Americans, Latinos and those with less education and income, according to a study by researchers at UC San Francisco.
Dr. Mary DiBartolo of Salisbury University’s Nursing Department is helping to educate and prepare others about the crisis facing the nation’s health care system related to the care of older adults.
Montefiore Health System and the Hebrew Home at Riverdale are proud to announce a unique partnership to improve care for patients requiring sub-acute rehabilitation at the Hebrew Home at Riverdale.
Simple images designed to convey information about prescription drugs could help save lives and reduce the economic burden of non-adherence to treatment. New research published in Applied Ergonomics shows that including pictograms on written medication instructions helps seniors take their drugs correctly.
Having comfortable living conditions and independence from their adult children can help elderly Chinese immigrants find a sense of home and life satisfaction in the United States, but the inability to speak fluent English makes them feel unsettled, according to a research study.
For many people, the prospect of aging is scary and uncomfortable, but Florida State University Assistant Professor Dawn Carr says that research reveals a few tips that can improve our chances of a long, healthy life.
In a new study, researchers used a nationally-representative dataset to estimate the frequency with which emergency providers make a formal diagnosis of elder abuse. The answer: 1 in 7,700 visits.
The following statement can be attributed to AMGA President and Chief Executive Officer Donald W. Fisher, Ph.D., CAE in response to the comments AMGA submitted to the Centers for Medicare & Medicaid Services (CMS) on the proposed rule regarding the Program of All-inclusive Care for the Elderly (PACE).
High folate (vitamin B9) consumption is associated with an increased risk for a nerve-damage disorder in older adults who have a common genetic variant linked to reduced cellular vitamin B12 availability
Researchers at University of California San Diego School of Medicine have confirmed that mutation-caused dysfunction in a process cells use to transport molecules within the cell plays a previously suspected but underappreciated role in promoting the heritable form of Alzheimer’s disease (AD), but also one that might be remedied with existing therapeutic enzyme inhibitors.
A new study shows just how much it costs to care for patients who suffer a complication after surgery, and how widely hospitals can vary in their ability to keep patients from suffering, or dying from, the same complications. It reveals that hospitals vary widely – as much as two- or three-fold -- in what they get paid for caring for patients with the same complications from the same operation.
How do you know when it's time for an older adult with mild dementia to stop driving? Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. It can impact a person's ability to drive safely. Although all people with dementia will have to stop driving eventually, each case can be unique based on the individual. According to a new study published in the Journal of the American Geriatrics Society, we still need to explore mental or physical tests that can best predict when people with dementia should stop driving.
The call for abstracts opens Friday, Sept. 30, for the second annual Optimal Aging Conference, hosted by the Univeristy of Louisville Institute for Sustainable Health & Optimal Aging and the Kentucky Association for Gerontology. The conference will be held June 11-13, 2017.
While the goal of filling out end-of-life forms is to let providers know patients’ preferences regarding life-sustaining treatments, the information they contain is often ambiguous, a new University at Buffalo study has found.
Researchers at Johns Hopkins report they have identified a protein that enables a toxic natural aggregate to spread from cell to cell in a mammal’s brain — and a way to block that protein’s action. Their study in mice and cultured cells suggests that an immunotherapy already in clinical trials as a cancer therapy should also be tested as a way to slow the progress of Parkinson’s disease, the researchers say.